Ocular Delivery System for Propranolol Hydrochloride Based on Nanostructured Lipid Carrier
Ocular Delivery System for Propranolol Hydrochloride Based on Nanostructured Lipid Carrier
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
One drawback of traditional forms of medical ocular dosage is drug dilution by tear; moreover, drugs are rapidly drained away from pre-corneal cavity by tear flow and lacrimo-nasal drainage. Prolonging contact time with different strategies and mucoadhesive vehicles will help to continuously deliver drugs to the eyes. For this study, we prepared an...
Alternative Titles
Full title
Ocular Delivery System for Propranolol Hydrochloride Based on Nanostructured Lipid Carrier
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c4e06bf0459240ac95b95b71d1bcb3e3
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c4e06bf0459240ac95b95b71d1bcb3e3
Other Identifiers
ISSN
2218-0532,0036-8709
E-ISSN
2218-0532
DOI
10.3390/scipharm86020016
